Mark Terrelonge, MD, MPH

Title(s)Assistant Professor, Neurology
SchoolSchool of Medicine
Address521 Parnassus Avenue, #2517
San Francisco CA 94117
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences

    Collapse Biography 
    Collapse Education and Training
    University of California San Francisco, San Francisco, CAFellowship06/2020Neuromuscular Medicine
    University of California San Francisco, San Francisco, CAResident06/2019Neurology
    Stanford School of Medicine, Palo Alto, CAMD06/2015
    Columbia Mailman School of Public Health, New York, NYMPH10/2014Biostatistics
    Harvard University, Cambridge, MABA06/2010Neurobiology
    University of California San Francisco , San Francisco, CA 09/2020Diversity, Equity, and Inclusion Champion Training
    Collapse Awards and Honors
    UCSF2023Cheryl Jay Master Clinician Award for Clinical Excellence in Neurology
    UCSF2023Haile T. Debas Academy of Medical Educators School of Medicine Excellence in Teaching Award
    UCSF2020John A. Watson Faculty Scholar
    UCSF2019Alpha Omega Alpha
    UCSF2017UCSF Teaching Excellence Award for Cherished Housestaff

    Collapse Overview 
    Collapse Overview
    Mark Terrelonge MD MPH is an Assistant Professor of Neurology and Neuromuscular Medicine at the University of California San Francisco and Assistant Program Director of the UCSF Neurology Residency. He sees patients with disorders of the nerve, muscle, neuromuscular junction, and spine. He also cares for general Neurology patients at the Zuckerberg San Francisco General Hospital, and Neuromuscular and ALS patients in the Fresno region. He has a special interest in patients from rural and underserved areas of California.

    Collapse Featured Content 
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Needs assessment for direct ophthalmoscopy training in neurology residency. BMC Med Educ. 2024 Mar 27; 24(1):344. Saroya J, Chahal N, Jiang A, Pet D, Rasool N, Terrelonge M, Yung M. PMID: 38539205; PMCID: PMC10967108.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Detection of High-Risk Paraneoplastic Antibodies against TRIM9 and TRIM67 Proteins. Ann Neurol. 2023 12; 94(6):1086-1101. Bartley CM, Ngo TT, Do LD, Zekeridou A, Dandekar R, Muñiz-Castrillo S, Alvarenga BD, Zorn KC, Tubati A, Pinto AL, Browne WD, Hullett PW, Terrelonge M, Schubert RD, Piquet AL, Yang B, Montalvo M, Kung AF, Mann SA, Shah MP, Geschwind MD, Gelfand JM, DeRisi JL, Pittock SJ, Honnorat J, Pleasure SJ, Wilson MR. PMID: 37632288; PMCID: PMC10842626.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. ALSUntangled #65: glucocorticoid corticosteroids. Amyotroph Lateral Scler Frontotemporal Degener. 2023 05; 24(3-4):351-357. Goslinga JA, Terrelonge M, Bedlack R, Barkhaus P, Barnes B, Bertorini T, Bromberg M, Carter G, Chen A, Crayle J, Dimachkie M, Jiang L, Levitsky G, Lund I, Martin S, Mcdermott C, Pattee G, Pierce K, Ratner D, Slachtova L, Sun Y, Wicks P. PMID: 35997522.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    4. Common Focal Neuropathies in the Hospitalized Patient. Neurol Clin. 2022 02; 40(1):175-190. Terrelonge M, Rosow L. PMID: 34798969.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    5. KIBRA, MTNR1B, and FKBP5 genotypes are associated with decreased odds of incident delirium in elderly post-surgical patients. Sci Rep. 2022 01 11; 12(1):556. Terrelonge M, LaHue SC, Tang C, Movsesyan I, Pullinger CR, Dubal DB, Leung J, Douglas VC. PMID: 35017578; PMCID: PMC8752781.
      View in: PubMed   Mentions: 1     Fields:    
    6. ALSUntangled #63: ketogenic diets. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Feb; 24(1-2):159-163. Bedlack R, Barkhaus PE, Barnes B, Beauchamp M, Bertorini T, Bromberg MB, Carter GT, Chaudry V, Cudkowicz M, Jackson C, Levitsky G, Lund I, McDermott C, Novella S, Olby N, Ostrow L, Pattee GL, Heiman-Patterson T, Ratner D, Salmon K, Steves S, Terrelonge M, Wicks P, Wills AM. PMID: 34645313.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    7. Outcomes Following Implementation of a Hospital-Wide, Multicomponent Delirium Care Pathway. J Hosp Med. 2021 07; 16(7):397-403. LaHue SC, Maselli J, Rogers S, Casatta J, Chao J, Croci R, Gonzales R, Holt B, Josephson SA, Lama S, Lau C, McCulloch C, Newman JC, Terrelonge M, Yeager J, Douglas VC. PMID: 34197303; PMCID: PMC9621338.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    8. CSF β-Amyloid 1-42 Predicts Progression to Cognitive Impairment in Newly Diagnosed Parkinson Disease. J Mol Neurosci. 2016 Jan; 58(1):88-92. Terrelonge M, Marder KS, Weintraub D, Alcalay RN. PMID: 26330275; PMCID: PMC4738011.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans